128 related articles for article (PubMed ID: 6205183)
1. [Serum pancreatic secretory trypsin inhibitor (PSTI), amylase activity and pancreatic isoamylase activity in pancreatic diseases].
Suehiro I; Otsuki M; Oka T; Okabayashi Y; Ohki A; Kanda T; Yuu H; Maeda M; Yamasaki T; Baba S
Nihon Shokakibyo Gakkai Zasshi; 1984 Apr; 81(4):1044-9. PubMed ID: 6205183
[No Abstract] [Full Text] [Related]
2. Serum pancreatic secretory trypsin inhibitor in pancreatic disease.
Otsuki M; Oka T; Suehiro I; Okabayashi Y; Ohki A; Yuu H; Baba S
Clin Chim Acta; 1984 Sep; 142(2):231-40. PubMed ID: 6209036
[TBL] [Abstract][Full Text] [Related]
3. The measurement of serum immunoreactive pancreatic secretory trypsin inhibitor in gastrointestinal cancer and pancreatic disease.
Satake K; Inui A; Sogabe T; Yoshii Y; Nakata B; Tanaka H; Chung YS; Hiura A; Umeyama K
Int J Pancreatol; 1988 Jul; 3(5):323-31. PubMed ID: 2459273
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and specificity of canine serum total amylase and isoamylase activity determinations.
Jacobs RM; Swenson CL; Davenport DJ; Murtaugh RJ
Can J Vet Res; 1988 Oct; 52(4):473-5. PubMed ID: 2461794
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum pancreatic enzymes in the quiescent phase of chronic pancreatitis.
Lesi C; Melzi D'Eril GV; Pavesi F; Scandellari A; Faccenda F; Grazia Casertano M; Savoia M; Zoni L; Peppi M
Clin Biochem; 1985 Aug; 18(4):235-8. PubMed ID: 2412726
[TBL] [Abstract][Full Text] [Related]
6. Amylase, pancreatic isoamylase and lipase in serum before and after endoscopic pancreatography.
Fjøsne U; Waldum HL; Romslo I; Kleveland PM; Johnsen H; Engebretsen LF
Acta Med Scand; 1986; 219(3):301-4. PubMed ID: 2422881
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of serum pancreatic isoamylase, lipase, and trypsin-like immunoreactivity in pancreatic disease.
Ventrucci M; Gullo L; Daniele C; Bartolucci C; Priori P; Platé L; Bonora G; Labò G
Digestion; 1983; 28(2):114-21. PubMed ID: 6197334
[TBL] [Abstract][Full Text] [Related]
8. Correlation of pancreatic enzyme levels with the patient's recovery from acute edematous pancreatitis.
Lankisch PG; Buschmann-Kaspari H; Otto J; Schröder K; Koop H
Klin Wochenschr; 1990 Jun; 68(11):565-9. PubMed ID: 1695957
[TBL] [Abstract][Full Text] [Related]
9. Concentration of immunoreactive trypsin and activity of pancreatic isoamylase in serum compared in pancreatic diseases.
Fahrenkrug J; Magid E
Clin Chem; 1980 Oct; 26(11):1573-6. PubMed ID: 6158383
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serum amylase pancreatic isoamylase and lipase in patients with hyperamylasemia.
Kolars JC; Ellis CJ; Levitt MD
Dig Dis Sci; 1984 Apr; 29(4):289-93. PubMed ID: 6200276
[TBL] [Abstract][Full Text] [Related]
11. Effects of xylazine administration on serum amylase, pancreas-specific isoamylase and pancreatic polypeptide in normal dogs.
Jacobs RM; Murtaugh RJ; Sherding RG; O'Dorisio TM
Can J Vet Res; 1986 Jan; 50(1):123-5. PubMed ID: 2427175
[TBL] [Abstract][Full Text] [Related]
12. Relation between serum pancreatic isoamylase concentration and pancreatic exocrine function.
Johnson SG; Levitt MD
Am J Dig Dis; 1978 Oct; 23(10):914-8. PubMed ID: 717351
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of immunoreactive PSTI in acute abdominal disorders, with special reference to a possible extrapancreatic PSTI production.
Lasson A; Borgström A; Ohlsson K
Clin Chim Acta; 1986 Nov; 161(1):37-46. PubMed ID: 2434267
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic significance of pancreatic serum-enzyme patterns after stimulation with secretin in chronic pancreatitis (author's transl)].
Malfertheiner P; Bieger W; Trischler G; Ditschuneit H
Dtsch Med Wochenschr; 1982 Jun; 107(22):849-53. PubMed ID: 6177482
[TBL] [Abstract][Full Text] [Related]
15. Extrapancreatic origin of chronic unexplained hyperamylasemia.
Levitt MD; Ellis CJ; Meier PB
N Engl J Med; 1980 Mar; 302(12):670-1. PubMed ID: 6153453
[No Abstract] [Full Text] [Related]
16. Elevated levels of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with malabsorption syndrome.
Nakano I; Funakoshi A; Kimura T; Miyata Y; Koga S; Ibayashi H
Gastroenterol Jpn; 1986 Dec; 21(6):617-22. PubMed ID: 2436966
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an inhibitor assay to determine serum isoamylase distribution.
Ellis C; Koehler DF; Eckfeldt JH; Levitt MD
Dig Dis Sci; 1982 Oct; 27(10):897-901. PubMed ID: 6180877
[TBL] [Abstract][Full Text] [Related]
18. Elevation of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with serious injury.
Ogawa M; Matsuda K; Shibata T; Matsuda Y; Ukai T; Ohta M; Mori T
Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):259-66. PubMed ID: 2417295
[TBL] [Abstract][Full Text] [Related]
19. Nonpancreatic-type hyperamylasemia associated with pancreatic cancer.
Shimamura J; Fridhandler L; Berk JE
Am J Dig Dis; 1976 Apr; 21(4):340-5. PubMed ID: 1274925
[TBL] [Abstract][Full Text] [Related]
20. Differential determination of serum isoamylase using an amylase inhibitor and its clinical application.
Kameya A; Hayakawa T; Noda A; Kondo T
Am J Gastroenterol; 1985 Jan; 80(1):54-9. PubMed ID: 3966456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
